Bioequivalence Study of Lornoxicam Tablets in Healthy Volunteers by LC-MS/MS Method

Quanying Zhang
2012-01-01
Abstract:OBJECTIVE To develop an LC-MS/MS method for the determination of lornoxicam in human plasma to evaluate the bioequivalence of lornoxicam in healthy volunteers.METHODS A single oral dose of 8 mg reference and test tablets were given to 20 healthy male volunteers according to a randomized crossover design.Plasma concentrations were determined by LC-MS/MS after deproteinized by methanol.The pharmacokinetic parameters were calculated by DAS 2.0.RESULTS The main pharmacokinetic parameters of lornoxicam in test and reference preparations were as follows:Cmax were(782.0±275.1) μg·L-1 and(823.4±256.1) μg·L-1,tmax were(2.8±1.4) h and(2.6±1.4) h,t1/2 were(3.5±1.2) and(3.3±0.8) h,AUC0-24 h were(4 545±1 714) and(4 516±2 054) μg·h·L-1,respectively.The relative bioavailability of lornoxicam was(103.8±15.0) %.CONCLUSION The method was proved to be accurate,sensitive and convenient;lornoxicam in the test tablets was bioequivalent to the reference tablets.
What problem does this paper attempt to address?